Invention Application
- Patent Title: FXR (NR1H4) MODULATING COMPOUNDS
-
Application No.: US17534951Application Date: 2021-11-24
-
Publication No.: US20220204491A1Publication Date: 2022-06-30
- Inventor: Peter A. Blomgren , Kevin S. Currie , Morin Mae Frick , Elizabeth M. Horstman , Joshua A. Kaplan , Jeffrey E. Kropf , William J. Watkins
- Applicant: Gilead Sciences, Inc.
- Applicant Address: US CA Foster City
- Assignee: Gilead Sciences, Inc.
- Current Assignee: Gilead Sciences, Inc.
- Current Assignee Address: US CA Foster City
- Main IPC: C07D413/14
- IPC: C07D413/14 ; A61P1/16

Abstract:
The present disclosure relates generally to compounds that bind to FXR and act as agonists of FXR. The disclosure further relates to the use of the compounds for the preparation of a medicament for the treatment of diseases and/or conditions through binding of said nuclear receptor by said compounds and to a process for the synthesis of said compounds.
Information query